AGT and cardiac hypertrophy: In mice, inhibition of miR-221 exacerbated Angiotensin II-induced cardiac fibrosis (interstitial collagen content increased by ~60%) and LV dysfunction (ejection fraction decreased by ~25%), without affecting cardiac hypertrophy [9].